Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

ClinicalTrials.gov ID: NCT05882045

Public ClinicalTrials.gov record NCT05882045. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 7:40 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Phase 3 Study to Investigate the Efficacy and Safety of LY3437943 Once Weekly Compared to Placebo in Participants With Severe Obesity and Established Cardiovascular Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and established cardiovascular disease (CVD). The study will last about 113 weeks.

Study identification

NCT ID
NCT05882045
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
1,946 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 30, 2023 (Actual)
Primary completion
Apr 16, 2026 (Actual)
Completion
May 14, 2026 (Actual)
Last update posted
Jul 30, 2026

2023 – 2026

United States locations

U.S. sites
46
U.S. states
22
U.S. cities
42
Facility City State ZIP Site status
Central Phoenix Medical Clinic Phoenix Arizona 85020 —
Valley Clinical Trials, Inc. Covina California 91723 —
Neuro-Pain Medical Center Fresno California 93710 —
Valley Research Fresno California 93720 —
Collaborative Neuroscience Research, LLC Los Alamitos California 90720 —
Velocity Clinical Research, Westlake Los Angeles California 90057 —
Valley Clinical Trials, Inc. Northridge California 91325 —
Velocity Clinical Research, Panorama City Van Nuys California 91405 —
Chase Medical Research, LLC Waterbury Connecticut 06708 —
Indago Research & Health Center, Inc Hialeah Florida 33012 —
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare Jacksonville Florida 32256 —
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801 —
Charter Research - Winter Park Orlando Florida 32803 —
Progressive Medical Research Port Orange Florida 32127 —
Pacific Diabetes & Endocrine Center Honolulu Hawaii 96817 —
Elite Clinical Trials Blackfoot Idaho 83221 —
Humphreys Diabetes Center Boise Idaho 83702 —
Northwestern University Chicago Illinois 60611 —
Great Lakes Clinical Trials - Gurnee Gurnee Illinois 60031 —
Central Illinois Diabetes and Clinical Research a Division of Prairie Education and Research Cooperative Springfield Illinois 62711 —
Brengle Family Medicine Indianapolis Indiana 46260 —
Iowa Diabetes and Endocrinology Research Center West Des Moines Iowa 50265 —
Cotton O'Neil Diabetes & Endocrinology Topeka Kansas 66606 —
MedVadis Research Corporation Waltham Massachusetts 02451 —
StudyMetrix Research City of Saint Peters Missouri 63303 —
Las Vegas Medical Research Las Vegas Nevada 89128 —
Palm Research Center Tenaya Las Vegas Nevada 89128 —
IMA Clinical Research Warren Warren Township New Jersey 07059 —
Weill Cornell Medical College New York New York 10021 —
Rochester Clinical Research, LLC Rochester New York 14609 —
Carteret Medical Group Morehead City North Carolina 28557 —
Cleveland Clinic Cleveland Ohio 44195 —
Altoona Center For Clinical Research Duncansville Pennsylvania 16635 —
UPMC Montefiore University Hospital Pittsburgh Pennsylvania 15213 —
Tribe Clinical Research, LLC Greenville South Carolina 29607 —
Trial Management Associates Myrtle Beach South Carolina 29572 —
Tribe Clinical Research - Spartanburg Spartanburg South Carolina 29301 —
Texas Diabetes & Endocrinology, P.A. Austin Texas 78731 —
Pinnacle Clinical Research Austin Texas 78757 —
South Texas Clinical Research Corpus Christi Texas 78404 —
Southern Endocrinology Associates Mesquite Texas 75149 —
Texas Diabetes & Endocrinology, P.A. Round Rock Texas 78681 —
Sleep Therapy Research Center San Antonio Texas 78229 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —
Advanced Research Institute Ogden Utah 84405 —
Rainier Clinical Research Center Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 123 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05882045, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2026 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05882045 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →